194 related articles for article (PubMed ID: 35545234)
1. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
[TBL] [Abstract][Full Text] [Related]
2. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole.
Mori H; Kuroda Y; Imamura S; Toyoda A; Yoshida I; Kawakami M; Tabei K
Intern Med; 2003 Aug; 42(8):665-9. PubMed ID: 12924488
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.
Lei H; Liu X; Zeng J; Fan Z; He Y; Li Z; Wang C
Pharmacology; 2022; 107(7-8):351-358. PubMed ID: 35381593
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole Induced Hyponatremia and Hyperkalemia, The Necessity of Electrolyte Follow-up in Every Patient.
Khorvash F; Moeinzadeh F; Saffaei A; Hakamifard A
Iran J Kidney Dis; 2019 Jul; 13(4):277-280. PubMed ID: 31422395
[TBL] [Abstract][Full Text] [Related]
6. Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia.
Noto H; Kaneko Y; Takano T; Kurokawa K
Intern Med; 1995 Feb; 34(2):96-9. PubMed ID: 7727887
[TBL] [Abstract][Full Text] [Related]
7. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
Greenberg S; Reiser IW; Chou SY; Porush JG
Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremia Associated With Standard-Dose Trimethoprim-Sulfamethoxazole Use in an Immunocompetent Patient.
Azeem A; Majeed N; Khuwaja S
WMJ; 2022 Oct; 121(3):E57-E59. PubMed ID: 36301661
[TBL] [Abstract][Full Text] [Related]
10. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
Witt JM; Koo JM; Danielson BD
Ann Pharmacother; 1996 Apr; 30(4):347-50. PubMed ID: 8729886
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications.
Gentry CA; Nguyen AT
Ann Pharmacother; 2013 Dec; 47(12):1618-26. PubMed ID: 24259630
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole and the risk of a hospital encounter with hyperkalemia: a matched population-based cohort study.
Hwang YJ; Muanda FT; McArthur E; Weir MA; Sontrop JM; Lam NN; Garg AX
Nephrol Dial Transplant; 2023 May; 38(6):1459-1468. PubMed ID: 36208171
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
Alappan R; Buller GK; Perazella MA
Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
[TBL] [Abstract][Full Text] [Related]
16. Is trimethoprim/sulfamethoxazole-associated increase in serum creatinine a pseudo-elevation or true nephrotoxicity?
Urakami T; Hamada Y; Oka Y; Kannae M; Okinaka T; Sanada A; Shimanoe C; Aoki Y
J Infect Chemother; 2021 Aug; 27(8):1193-1197. PubMed ID: 33832848
[TBL] [Abstract][Full Text] [Related]
17. Effect of Prophylactic Dose of Trimethoprim-Sulfamethoxazole on Serum Creatinine in Japanese Patients With Connective Tissue Diseases.
Kawato R; Rokutanda R; Okada M; Matsushita M; Yamaji K; Tamura N
Clin Med Insights Arthritis Musculoskelet Disord; 2022; 15():11795441221085141. PubMed ID: 35342315
[TBL] [Abstract][Full Text] [Related]
18. Case report: reversible hyperkalemia associated with trimethoprim- sulfamethoxazole.
Marinella MA
Am J Med Sci; 1995 Sep; 310(3):115-7. PubMed ID: 7668307
[TBL] [Abstract][Full Text] [Related]
19. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Nguyen AT; Gentry CA; Furrh RZ
Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture?
Ackerman BH; Patton ML; Guilday RE; Haith LR; Stair-Buchmann M; Reigart CL
J Burn Care Res; 2013; 34(1):127-32. PubMed ID: 23292580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
